Literature DB >> 15029463

99mTc-EDDA/HYNIC-TOC scintigraphy in the differential diagnosis of solitary pulmonary nodules.

Anna Płachcińska1, Renata Mikołajczak, Helmut R Maecke, Andrzej Michalski, Katarzyna Rzeszutek, Józef Kozak, Jacek Kuśmierek.   

Abstract

Forty-three consecutive patients with solitary pulmonary nodules (SPNs) on chest radiographs were studied scintigraphically after administration of the somatostatin analogue (99m)Tc-EDDA/HYNIC-TOC. The objective of the study was to assess the usefulness of the procedure for differentiation of SPNs as malignant or benign. The administered activity was 740-925 MBq, and a single-photon emission computed tomography imaging technique was employed. Verification of the nodule aetiology was based on histology or cytology and bacteriology. A stable tumour size on chest radiography for at least 3 years was accepted as an additional criterion of benignity. In 29 patients, nodules were found to be malignant. The diagnoses included ten adenocarcinomas, five squamous cell carcinomas, two large cell carcinomas, six non-small cell lung cancers without specification of the more detailed morphology, two small cell lung cancers, two typical carcinoids and two metastatic tumours (leiomyosarcoma and malignant melanoma). In 14 patients the following benign tumours were diagnosed: four tuberculomas, one other granuloma, three hamartomas, one non-specific inflammatory infiltrate, one abscess, one peripheral carcinoid with the morphological characteristics of a benign tumour, one ectopic lesion of thyroid tissue and two benign tumours of unspecified aetiology with a stable size over 3 and 5 years respectively. Positive scintigraphic results were obtained in 26 of the 29 patients (90%) with malignant SPNs; among these, 24 of the 25 (96%) cases of primary pulmonary carcinoma yielded positive results. The remaining two false negative cases were the metastatic tumours, liposarcoma and melanoma. Of the 14 benign lesions, ten (71%) did not accumulate the radiopharmaceutical. The remaining four benign tumours that were visible on scintigrams comprised one tuberculoma, one hamartoma, one abscess and one case in which the diagnosis could not be established (the tumour had a stable size over 3 years). In conclusion, scintigraphy with (99m)Tc-EDDA/HYNIC-TOC appears to be an effective procedure for differentiation between malignant and benign SPNs. A fully credible assessment of the clinical efficacy of this procedure requires further study in a larger number of patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15029463     DOI: 10.1007/s00259-004-1511-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  16 in total

1.  Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.

Authors:  C Decristoforo; S J Mather
Journal:  Eur J Nucl Med       Date:  1999-08

Review 2.  Clinical practice. The solitary pulmonary nodule.

Authors:  David Ost; Alan M Fein; Steven H Feinsilver
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

3.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

4.  Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT.

Authors:  M Zhang; M Kono
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

5.  Significance of a single pulmonary nodule in patients with previous history of malignancy.

Authors:  A Sortini; P Carcoforo; S Ascanelli; D Sortini; E Pozza
Journal:  Eur J Cardiothorac Surg       Date:  2001-12       Impact factor: 4.191

6.  99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.

Authors:  C Decristoforo; L Melendez-Alafort; J K Sosabowski; S J Mather
Journal:  J Nucl Med       Date:  2000-06       Impact factor: 10.057

7.  Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory.

Authors:  J W Gurney
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

8.  Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.

Authors:  V J Lowe; J M Hoffman; D M DeLong; E F Patz; R E Coleman
Journal:  J Nucl Med       Date:  1994-11       Impact factor: 10.057

9.  Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

Authors:  M K Gould; C C Maclean; W G Kuschner; C E Rydzak; D K Owens
Journal:  JAMA       Date:  2001-02-21       Impact factor: 56.272

Review 10.  Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.

Authors:  E P Krenning; D J Kwekkeboom; W H Bakker; W A Breeman; P P Kooij; H Y Oei; M van Hagen; P T Postema; M de Jong; J C Reubi
Journal:  Eur J Nucl Med       Date:  1993-08
View more
  7 in total

Review 1.  Somatostatin receptor scintigraphy in thoracic diseases.

Authors:  P Ameri; F Gatto; M Arvigo; G Villa; E Resmini; F Minuto; G Murialdo; D Ferone
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

2.  Differential diagnosis of solitary pulmonary nodules using ⁹⁹mTc-3P₄-RGD₂ scintigraphy.

Authors:  Qingjie Ma; Bin Ji; Bing Jia; Shi Gao; Tiefeng Ji; Xueju Wang; Zhenguo Han; Guoqing Zhao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-27       Impact factor: 9.236

3.  Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: the effect of tumour size on the optimal method of image assessment.

Authors:  Anna Płachcińska; Renata Mikołajczak; Józef Kozak; Katarzyna Rzeszutek; Jacek Kuśmierek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-16       Impact factor: 9.236

4.  (99m)Tc-HYNIC-TOC scintigraphy in evaluation of active Graves' ophthalmopathy (GO).

Authors:  Hua Sun; Xu-Feng Jiang; Shu Wang; Hao-Yan Chen; Jiao Sun; Pei-Yong Li; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

5.  Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy.

Authors:  Rong Zhao; Jiang Wang; Jinglan Deng; Weidong Yang; Jing Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

6.  Predictive Value of 99MTC-hynic-toc Scintigraphy in Lung Neuroendocrine Tumor Diagnosis.

Authors:  Efimia Boutsikou; Konstantinos Porpodis; Vasiliki Chatzipavlidou; Georgia Hardavella; George Gerasimou; Kalliopi Domvri; Nikitas Papadopoulos; Vasiliki Avramidou; Dionisis Spyratos; Theodoros Kontakiotis; Konstantinos Zarogoulidis
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

7.  The role of octreotate scan in discrimination of solitary pulmonary nodule.

Authors:  Fariba Rezaeetalab; Kamran Aryana; Davood Attaran; Reza Bagheri; Farshid Nattagh; Shahrzad Mohamadzadeh Lari
Journal:  World J Nucl Med       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.